Percutaneous Coronary Intervention of Arterial and Vein Grafts
Bimmer Claessen
Search for more papers by this authorFrans Beerkens
Search for more papers by this authorJosé P.S. Henriques
Search for more papers by this authorGeorge D. Dangas
Search for more papers by this authorBimmer Claessen
Search for more papers by this authorFrans Beerkens
Search for more papers by this authorJosé P.S. Henriques
Search for more papers by this authorGeorge D. Dangas
Search for more papers by this authorGeorge D. Dangas MD, MACC, MSCAI, FAHA, FESC
Professor of Medicine (Cardiology) & Surgery (Vascular) Professor of Cardiology Adjunct Professor of Internal Medicine
Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, New York, NY, USA
National Kapodistrian University of Athens, Greece
Medical University of Vienna, Austria
Search for more papers by this authorCarlo Di Mario MD, PhD, FRCP, FACC, FSCAI, FESC
Professor of Cardiology Director of the Structural Interventional Cardiology Division Honorary Consultant
University of Florence
University Hospital Careggi, Florence, Italy
Cardiologist Royal Brompton Hospital, London, UK
Search for more papers by this authorHolger Thiele MD
Professor of Cardiology at University of Leipzig
Heart Center Leipzig at University of Leipzig, Leipzig, Germany
Search for more papers by this authorPeter Barlis MBBS, MPH, PHD, FACC, FESC, FRACP
Professor of Cardiology Interventional Cardiologist
University of Melbourne, Melbourne, Victoria, Australia
St Vincent's & Northern Hospitals Victoria, Australia
Search for more papers by this authorSummary
This chapter provides an overview of the indications and challenges of percutaneous coronary intervention (PCI) in patients with failing arterial or venous bypass grafts. Long-term results of coronary artery bypass graft surgery (CABG) surgery are limited by the gradual progression of coronary artery disease in the native vessels and gradual failure of bypass conduits. Late failure of bypass graft conduits most often results from attrition of saphenous vein grafts and/or progression of atherosclerotic disease in the native coronary arteries. Graft occlusion of venous conduits within the first year after CABG surgery occurs in approximately 3–10% of patients in contemporary trials and registries. Treatment of SVGs with PCI is associated with high rates of complications and major adverse cardiac events. Factors favoring PCI over CABG include limited areas of ischemia causing symptoms, suitable PCI targets, a patent graft to the left anterior descending artery artery, poor CABG targets, and comorbid conditions.
References
- Cheng TO . History of coronary artery bypass surgery--half of a century of progress . Int Jnl Cardiol. 2012 ; 157 ( 1 ): 1 – 2 .
- Epstein AJ , Polsky D , Yang F , et al . Coronary revascularization trends in the United States, 2001–2008 . JAMA. 2011 ; 305 ( 17 ): 1769 – 76 .
- Farkouh ME , Domanski M , Sleeper LA , et al . Strategies for multivessel revascularization in patients with diabetes . N Engl J Med. 2012 ; 367 ( 25 ): 2375 – 84 .
- Group BDS , Frye RL , August P , et al . A randomized trial of therapies for type 2 diabetes and coronary artery disease . N Engl J Med. 2009 ; 360 ( 24 ): 2503 – 15 .
- Mohr FW , Morice MC , Kappetein AP , et al . Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial . The Lancet. 2013 ; 381 ( 9867 ): 629 – 38 .
- Sabik JF , 3rd , Blackstone EH , Gillinov AM , et al . Occurrence and risk factors for reintervention after coronary artery bypass grafting . Circulation. 2006 ; 114 ( 1 Suppl ): I454 – 60 .
- Brilakis ES , Rao SV , Banerjee S , et al . Percutaneous coronary intervention in native arteries versus bypass grafts in prior coronary artery bypass grafting patients: a report from the National Cardiovascular Data Registry . JACC Cardiovascular Interventions. 2011 ; 4 ( 8 ): 844 – 50 .
- Serruys PW , Morice MC , Kappetein AP , et al . Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease . N Engl J Med. 2009 ; 360 ( 10 ): 961 – 72 .
- Thielmann M , Massoudy P , Jaeger BR , et al . Emergency re-revascularization with percutaneous coronary intervention, reoperation, or conservative treatment in patients with acute perioperative graft failure following coronary artery bypass surgery . Eur J Cardio-thor Surg. 2006 ; 30 ( 1 ): 117 – 25 .
- Harskamp RE , Lopes RD , Baisden CE , et al . Saphenous vein graft failure after coronary artery bypass surgery: pathophysiology, management, and future directions . Annals of Surgery. 2013 ; 257 ( 5 ): 824 – 33 .
- Stone GW , Sabik JF , Serruys PW , et al . Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease . N Engl Jnl Med. 2016 ; 375 ( 23 ): 2223 – 35 .
- Goldman S , Zadina K , Moritz T , et al . Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs Cooperative Study . J Am Coll Cardiol . 2004 ; 44 ( 11 ): 2149 – 56 .
- Gaudino M , Benedetto U , Fremes S , et al . Radial-Artery or Saphenous-Vein Grafts in Coronary-Artery Bypass Surgery . N Engl J Med. 2018 ; 378 ( 22 ): 2069 – 77 .
- Yi G , Shine B , Rehman SM , et al . Effect of bilateral internal mammary artery grafts on long-term survival: a meta-analysis approach . Circulation. 2014 ; 130 ( 7 ): 539 – 45 .
- Parasca CA , Head SJ , Mohr FW , et al . The impact of a second arterial graft on 5-year outcomes after coronary artery bypass grafting in the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery Trial and Registry . J Thorac Cardiovasc Surg , 150 ( 3 ), pp. 597 – 606 .e2.
- Taggart DP , Altman DG , Gray AM , et al . Randomized Trial of Bilateral versus Single Internal-Thoracic-Artery Grafts . N Engl Jnl Med. 2016 ; 375 ( 26 ): 2540 – 9 .
- Taggart DP , Benedetto U , Gerry S , et al . Bilateral versus Single Internal-Thoracic-Artery Grafts at 10 Years . N Engl Jnl Med. 2019 ; 380 ( 5 ): 437 – 46 .
- Fihn SD , Blankenship JC , Alexander KP , et al . 2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons . J Am Coll Cardiol . 2014 ; 64 ( 18 ): 1929 – 49 .
- Authors/Task Force m , Windecker S , Kolh P , et al . 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) . Eur Heart J . 2014 ; 35 ( 37 ): 2541 – 619 .
- Neumann FJ , Sousa-Uva M , Ahlsson A , et al . 2018 ESC/EACTS Guidelines on myocardial revascularization . Eur Heart J . 2019 ; 40 ( 2 ): 87 – 165 .
- Hillis LD , Smith PK , Anderson JL , et al . 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons . J Am Coll Cardiol . 2011 ; 58 ( 24 ): e123 – 210 .
- Brener SJ , Lytle BW , Casserly IP , et al . Predictors of revascularization method and long-term outcome of percutaneous coronary intervention or repeat coronary bypass surgery in patients with multivessel coronary disease and previous coronary bypass surgery . Eur Heart J. 2006 ; 27 ( 4 ): 413 – 8 .
- Harskamp RE , Beijk MA , Damman P , et al . Clinical outcome after surgical or percutaneous revascularization in coronary bypass graft failure . J Cardiovasc Med (Hagerstown). 2013 ; 14 ( 6 ): 438 – 45 .
- Locker C , Greiten LE , Bell MR , et al . Repeat Coronary Bypass Surgery or Percutaneous Coronary Intervention After Previous Surgical Revascularization . Mayo Clin Proc. 2019 ; 94 ( 9 ): 1743 – 52 .
- Morrison DA , Sethi G , Sacks J , et al . Percutaneous coronary intervention versus repeat bypass surgery for patients with medically refractory myocardial ischemia: AWESOME randomized trial and registry experience with post-CABG patients . J Am Coll Cardiol. 2002 ; 40 ( 11 ): 1951 – 4 .
- McKavanagh P , Yanagawa B , Zawadowski G , Cheema A . Management and Prevention of Saphenous Vein Graft Failure: A Review . Cardiol Ther. 2017 ; 6 ( 2 ): 203 – 23 .
- Oshima H , Tokuda Y , Araki Y , Ishii H , Murohara T , Ozaki Y , et al . Predictors of early graft failure after coronary artery bypass grafting for chronic total occlusion . Int CardioVasc Thorac Surg. 2016 ; 23 ( 1 ): 142 – 9 .
- Alqahtani F , Ziada KM , Badhwar V , Sandhu G , Rihal CS , Alkhouli M . Incidence, Predictors, and Outcomes of In-Hospital Percutaneous Coronary Intervention Following Coronary Artery Bypass Grafting . J Am Coll Cardiol. 2019 ; 73 ( 4 ): 415 – 23 .
- Thielmann M , Massoudy P , Schmermund A , et al . Diagnostic discrimination between graft-related and non-graft-related perioperative myocardial infarction with cardiac troponin I after coronary artery bypass surgery . Eur Heart J. 2005 ; 26 ( 22 ): 2440 – 7 .
- Babiker A , Del Angel JG , Perez-Vizcayno MJ , et al . Rescue percutaneous intervention for acute complications of coronary artery surgery . EuroIntervention 2009 ; 5 Suppl D : D64 – 9 .
- Claessen BE , Henriques JP , Jaffer FA , et al . Stent thrombosis: a clinical perspective . JACC Cardiovascular Interventions. 2014 ; 7 ( 10 ): 1081 – 92 .
- Brilakis ES , Wang TY , Rao SV , et al . Frequency and predictors of drug-eluting stent use in saphenous vein bypass graft percutaneous coronary interventions: a report from the American College of Cardiology National Cardiovascular Data CathPCI registry . JACC Cardiovascular Interventions. 2010 ; 3 ( 10 ): 1068 – 73 .
- Brilakis ES , O'Donnell CI , Penny W , et al . Percutaneous Coronary Intervention in Native Coronary Arteries Versus Bypass Grafts in Patients With Prior Coronary Artery Bypass Graft Surgery: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program . JACC Cardiovascular interventions. 2016 ; 9 ( 9 ): 884 – 93 .
- Lee MS , Park S-J , Kandzari DE , et al . Saphenous Vein Graft Intervention . JACC: Cardiovascular Interventions. 2011 ; 4 ( 8 ): 831 .
- Sturm E , Goldberg D , Goldberg S . Embolic protection devices in saphenous vein graft and native vessel percutaneous intervention: a review . Current Cardiology Reviews. 2012 ; 8 ( 3 ): 192 – 9 .
- Coolong A , Baim DS , Kuntz RE , et al . Saphenous vein graft stenting and major adverse cardiac events: a predictive model derived from a pooled analysis of 3958 patients . Circulation. 2008 ; 117 ( 6 ): 790 – 7 .
- Naidu SS , Turco MA , Mauri L , et al . Contemporary incidence and predictors of major adverse cardiac events after saphenous vein graft intervention with embolic protection (an AMEthyst trial substudy) . Am J Cardiol. 2010 ; 105 ( 8 ): 1060 – 4 .
- Hong MK , Mehran R , Dangas G , et al . Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality . Circulation. 1999 ; 100 ( 24 ): 2400 – 5 .
- Kirtane AJ , Heyman ER , Metzger C , et al . Correlates of adverse events during saphenous vein graft intervention with distal embolic protection: a PRIDE substudy . JACC Cardiovascular Interventions. 2008 ; 1 ( 2 ): 186 – 91 .
- Lee MS , Hu PP , Aragon J , et al . Impact of chronic renal insufficiency on clinical outcomes in patients undergoing saphenous vein graft intervention with drug-eluting stents: a multicenter Southern Californian Registry . Catheterization and Cardiovascular Interventions 2010 ; 76 ( 2 ): 272 – 8 .
- Ahmed JM , Dangas G , Lansky AJ , et al . Influence of gender on early and one-year clinical outcomes after saphenous vein graft stenting . Am J Cardiol. 2001 ; 87 ( 4 ): 401 – 5 .
- Ahmed JM , Hong MK , Mehran R , et al . Influence of diabetes mellitus on early and late clinical outcomes in saphenous vein graft stenting . J Am Coll Cardiol. 2000 ; 36 ( 4 ): 1186 – 93 .
- Dangas GD , Kini AS , Sharma SK , et al . Impact of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump on prognostically important clinical outcomes in patients undergoing high-risk percutaneous coronary intervention (from the PROTECT II randomized trial) . Amer J Cardiol. 2014 ; 113 ( 2 ): 222 – 8 .
- O'Neill WW , Kleiman NS , Moses J , et al . A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study . Circulation. 2012 ; 126 ( 14 ): 1717 – 27 .
- Michael TT , Alomar M , Papayannis A , et al . A randomized comparison of the transradial and transfemoral approaches for coronary artery bypass graft angiography and intervention: the RADIAL-CABG Trial (RADIAL Versus Femoral Access for Coronary Artery Bypass Graft Angiography and Intervention) . JACC Cardiovascular Interventions. 2013 ; 6 ( 11 ): 1138 – 44 .
- Israeli Z , Lavi S , Pancholy SB , et al . Radial versus femoral approach for saphenous vein grafts angiography and interventions . Amer Heart J. 2019 ; 210 : 1 – 8 .
- Bundhoo SS , Earp E , Ivanauskiene T , et al . Saphenous vein graft percutaneous coronary intervention via radial artery access: safe and effective with reduced hospital length of stay . Amer Heart J. 2012 ; 164 ( 4 ): 468 – 72 .
- Hindnavis V , Cho SH , Goldberg S . Saphenous vein graft intervention: a review . Jnl Invasive Cardiol. 2012 ; 24 ( 2 ): 64 – 71 .
- Navarese EP , Tandjung K , Claessen B , et al . Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: comprehensive network meta-analysis . BMJ. 2013 ; 347 : f6530 .
- Palmerini T , Biondi-Zoccai G , Della Riva D , et al . Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis . The Lancet. 2012 ; 379 ( 9824 ): 1393 – 402 .
- Jeger RV , Schneiter S , Kaiser C , et al . Drug-eluting stents compared with bare metal stents improve late outcome after saphenous vein graft but not after large native vessel interventions . Cardiology. 2009 ; 112 ( 1 ): 49 – 55 .
- Vermeersch P , Agostoni P , Verheye S , et al . Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC Trial . J Am Coll Cardiol. 2007 ; 50 ( 3 ): 261 – 7 .
- Brilakis ES , Lichtenwalter C , Abdul-rahman R , et al . Continued benefit from paclitaxel-eluting compared with bare-metal stent implantation in saphenous vein graft lesions during long-term follow-up of the SOS (Stenting of Saphenous Vein Grafts) trial . JACC: Cardiovascular Interventions. 2011 ; 4 ( 2 ): 176 – 82 .
- Colleran R , Kufner S , Mehilli J , et al . Efficacy over time with drug-eluting stents in saphenous vein graft lesions . J Am Coll Cardiol. 2018 ; 71 ( 18 ): 1973 – 82 .
- Brilakis ES , Edson R , Bhatt DL , et al . Drug-eluting stents versus bare-metal stents in saphenous vein grafts: a double-blind, randomised trial . The Lancet. 2018 ; 391 ( 10134 ): 1997 – 2007 .
- Shah R , Hesterberg K . Drug-eluting stents versus bare-metal stents for saphenous vein graft interventions . Jnl Thoracic Disease. 2019 ; 11 ( Suppl 9 ): S1257 .
- Patel NJ , Bavishi C , Atti V , et al . Drug-Eluting Stents Versus Bare-Metal Stents in Saphenous Vein Graft Intervention . Circ Cardiovasc Interv. 2018 ; 11 ( 11 ): e007045 .
- Baim DS , Wahr D , George B , et al . Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts . Circulation. 2002 ; 105 ( 11 ): 1285 – 90 .
- Carrozza JP , Jr. , Mumma M , Breall JA , et al . Randomized evaluation of the TriActiv balloon-protection flush and extraction system for the treatment of saphenous vein graft disease . J Am Coll Cardiol. 2005 ; 46 ( 9 ): 1677 – 83 .
- Stone GW , Rogers C , Hermiller J , et al . Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts . Circulation. 2003 ; 108 ( 5 ): 548 – 53 .
- Valle JA , Glorioso TJ , Schuetze KB , et al . Contemporary Use of Embolic Protection Devices During Saphenous Vein Graft Intervention . Circ Cardiovasc Interv. 2019 ; 12 ( 5 ): e007636 .
- Dixon SR , Mann JT , Lauer MA , et al . A randomized, controlled trial of saphenous vein graft intervention with a filter-based distal embolic protection device: TRAP trial . Jnl Intervent Cardiol. 2005 ; 18 ( 4 ): 233 – 41 .
- Brennan JM , Al-Hejily W , Dai D , et al . Three-year outcomes associated with embolic protection in saphenous vein graft intervention: results in 49 325 senior patients in the Medicare-linked National Cardiovascular Data Registry CathPCI Registry . Circ Cardiovasc Interv. 2015 ; 8 ( 3 ): e001403 .
- Shoaib A , Kinnaird T , Curzen N , et al . Outcomes Following Percutaneous Coronary Intervention in Saphenous Vein Grafts With and Without Embolic Protection Devices . JACC Cardiovascular interventions. 2019 ; 12 ( 22 ): 2286 – 95 .
- Levine GN , Bates ER , Blankenship JC , et al . 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions . J Am Coll Cardiol . 2011 ; 58 ( 24 ): e44 – 122 .
- Quan VH , Huynh R , Seifert PA , et al . Morphometric analysis of particulate debris extracted by four different embolic protection devices from coronary arteries, aortocoronary saphenous vein conduits, and carotid arteries . Am J Cardiol. 2005 ; 95 ( 12 ): 1415 – 9 .
- Mauri L , Cox D , Hermiller J , et al . The PROXIMAL trial: proximal protection during saphenous vein graft intervention using the Proxis Embolic Protection System: a randomized, prospective, multicenter clinical trial . J Am Coll Cardiol. 2007 ; 50 ( 15 ): 1442 – 9 .
- Stone GW , Goldberg S , O'Shaughnessy C , et al . 5-year follow-up of polytetrafluoroethylene-covered stents compared with bare-metal stents in aortocoronary saphenous vein grafts the randomized BARRICADE (barrier approach to restenosis: restrict intima to curtail adverse events) trial . JACC Cardiovascular Interventions. 2011 ; 4 ( 3 ): 300 – 9 .
- Vaknin-Assa H , Assali A , Lev EI , et al . Long Term Outcomes of MGuard Stent Deployment in Saphenous Vein Grafts and Native Coronary Arteries: A Single Center Experience . Isr Med Assoc J. 2017 ; 19 ( 3 ): 172 – 6 .
-
Kaplan BM
,
Benzuly KH
,
Kinn JW
,
et al
.
Treatment of no-reflow in degenerated saphenous vein graft interventions: comparison of intracoronary verapamil and nitroglycerin
.
Cathet Cardiovasc Diag.
1996
;
39
(
2
):
113
–
8
.
10.1002/(SICI)1097-0304(199610)39:2<113::AID-CCD1>3.0.CO;2-I CAS PubMed Web of Science® Google Scholar
- Kapoor N , Yalamanchili V , Siddiqui T , et al . Cardioprotective effect of high-dose intragraft adenosine infusion on microvascular function and prevention of no-reflow during saphenous vein grafts intervention . Cathet Cardiovasc Int. 2014 ; 83 ( 7 ): 1045 – 54 .
- Michaels AD , Appleby M , Otten MH , et al . Pretreatment with intragraft verapamil prior to percutaneous coronary intervention of saphenous vein graft lesions: results of the randomized, controlled vasodilator prevention on no-reflow (VAPOR) trial . Jnl Invasive Cardiol. 2002 ; 14 ( 6 ): 299 – 302 .
- Sdringola S , Assali A , Ghani M , et al . Adenosine use during aortocoronary vein graft interventions reverses but does not prevent the slow-no reflow phenomenon . Cathet Cardiovasc Int. 2000 ; 51 ( 4 ): 394 – 9 .
- Fischell TA , Subraya RG , Ashraf K , et al . “Pharmacologic” distal protection using prophylactic, intragraft nicardipine to prevent no-reflow and non-Q-wave myocardial infarction during elective saphenous vein graft intervention . Jnl Invasive Cardiol . 2007 ; 19 ( 2 ): 58 – 62 .
- Zoghbi GJ , Goyal M , Hage F , et al . Pretreatment with nitroprusside for microcirculatory protection in saphenous vein graft interventions . Jnl Invasive Cardiol. 2009 ; 21 ( 2 ): 34 – 9 .
- Roffi M , Mukherjee D , Chew DP , et al . Lack of benefit from intravenous platelet glycoprotein IIb/IIIa receptor inhibition as adjunctive treatment for percutaneous interventions of aortocoronary bypass grafts: a pooled analysis of five randomized clinical trials . Circulation. 2002 ; 106 ( 24 ): 3063 – 7 .
- Pucelikova T , Mehran R , Kirtane AJ , et al . Short- and long-term outcomes after stent-assisted percutaneous treatment of saphenous vein grafts in the drug-eluting stent era . Am J Cardiol. 2008 ; 101 ( 1 ): 63 – 8 .
- Hong YJ , Pichard AD , Mintz GS , et al . Outcome of undersized drug-eluting stents for percutaneous coronary intervention of saphenous vein graft lesions . Am J Cardiol. 2010 ; 105 ( 2 ): 179 – 85 .
- Niccoli G , Belloni F , Cosentino N , et al . Case-control registry of excimer laser coronary angioplasty versus distal protection devices in patients with acute coronary syndromes due to saphenous vein graft disease . Am J Cardiol. 2013 ; 112 ( 10 ): 1586 – 91 .
- Latif F , Uyeda L , Edson R , et al . Stent-Only Versus Adjunctive Balloon Angioplasty Approach for Saphenous Vein Graft Percutaneous Coronary Intervention: Insights From DIVA Trial . Circ Cardiovasc Interv. 2020 ; 13 ( 2 ): e008494 .
- Gruberg L , Hong MK , Mehran R , et al . In-hospital and long-term results of stent deployment compared with balloon angioplasty for treatment of narrowing at the saphenous vein graft distal anastomosis site . Am J Cardiol. 1999 ; 84 ( 12 ): 1381 – 4 .
- Ashby DT , Dangas G , Aymong EA , et al . Effect of percutaneous coronary interventions for in-stent restenosis in degenerated saphenous vein grafts without distal embolic protection . J Am Coll Cardiol. 2003 ; 41 ( 5 ): 749 – 52 .
- Januszek RA , Dziewierz A , Siudak Z , et al . Predictors of periprocedural complications in patients undergoing percutaneous coronary interventions within coronary artery bypass grafts . Cardiol J . 2019 ; 26 ( 6 ) 633 – 44 . doi: 10.5603/CJ.a2018.0044. Epub 2018 Apr 19. PMID: 29671862.
- Gruberg L , Dangas G , Mehran R , et al . Percutaneous revascularization of the internal mammary artery graft: short-and long-term outcomes . J Am Coll Cardiol. 2000 ; 35 ( 4 ): 944 – 8 .
- Sharma AK , Ajani AE , Garg N , et al . Percutaneous interventions in radial artery grafts: clinical and angiographic outcomes . Catheter Cardiovasc Interv. 2003 ; 59 ( 2 ): 172 – 5 .
- Buch AN , Xue Z , Gevorkian N , et al . Comparison of outcomes between bare metal stents and drug-eluting stents for percutaneous revascularization of internal mammary grafts . Am J Cardiol. 2006 ; 98 ( 6 ): 722 – 4 .